AOXG (Aoxing Pharmaceutical Co) Total Liabilities: $44.38 Mil (As of Mar. 2017)


What is Aoxing Pharmaceutical Co Total Liabilities?

Aoxing Pharmaceutical Co AOXG Total Liabilities is $44.38 Mil as of Mar. 2017.

Aoxing Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2017 was $44.38 Mil.

Aoxing Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2016 ($40.26 Mil) to Dec. 2016 ($40.92 Mil) and increased from Dec. 2016 ($40.92 Mil) to Mar. 2017 ($44.38 Mil).

Aoxing Pharmaceutical Co's annual Total Liabilities increased from Jun. 2014 ($42.08 Mil) to Jun. 2015 ($42.98 Mil) but then declined from Jun. 2015 ($42.98 Mil) to Jun. 2016 ($38.16 Mil).

Aoxing Pharmaceutical Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Aoxing Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aoxing Pharmaceutical Co Total Liabilities Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.83 35.15 42.08 42.98 38.16

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.38 38.16 40.26 40.92 44.38

Aoxing Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Aoxing Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Jun. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=37.816+(0+-3.7192471324943E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.34+0+0)
=38.16

Total Liabilities=Total Assets (A: Jun. 2016 )-Total Equity (A: Jun. 2016 )
=56.232-18.076
=38.16

Aoxing Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2017 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=43.971+(0.1+6.0507154842071E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.309+0+0)
=44.38

Total Liabilities=Total Assets (Q: Mar. 2017 )-Total Equity (Q: Mar. 2017 )
=62.466-18.086
=44.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $44.38 Mil mean?
Aoxing Pharmaceutical Co (AOXG) has a Total Liabilities of $44.38 Mil as of Mar. 2017. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Aoxing Pharmaceutical Co and its competitors.
Is Aoxing Pharmaceutical Co's Total Liabilities too high?
Aoxing Pharmaceutical Co's current Total Liabilities is $44.38 Mil.
How does Aoxing Pharmaceutical Co's Total Liabilities compare to OWCP and BSPK?
Aoxing Pharmaceutical Co's Total Liabilities of $44.38 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Diversified Financial Services company?
A good Total Liabilities depends on the Diversified Financial Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Aoxing Pharmaceutical Co and its competitors. Aoxing Pharmaceutical Co's current Total Liabilities is $44.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxing Pharmaceutical Co stock overvalued right now?
Aoxing Pharmaceutical Co (AOXG) has a current Total Liabilities of $44.38 Mil. The current Total Liabilities is $44.38 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Aoxing Pharmaceutical Co (AOXG), the current Total Liabilities is $44.38 Mil as of Mar. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aoxing Pharmaceutical Co Business Description

Address Block 25, Flat F, 9th Floor, South Horizons, Apleichau, Hong Kong, HKG
Aoxing Pharmaceutical Co Inc does not have any business operations and is restructuring for a new business model and plans to acquire an operating company via reverse merger.